Kalorama Information

The Market Intelligence Leader for the Diagnostics, Healthcare, and Healthcare IT Industries

[Kalorama Information @KaloramaInfo]

"#IVD is a $113BN market, up from $99BN in 2020."

VIDEO: Exciting news from @KaloramaInfo's "The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 18th Edition (2025-2030).

#ThoughtLeaders #mrx #diagnostics #healthcare #InVitroDiagnostics #Science #Medicine #MarketResearch

[Kalorama Information @KaloramaInfo]

The global sepsis diagnostics market is dynamic, but without reliable data on end-user spending, R&D can feel like a gamble. Kalorama's report turns uncertainty into a strategic roadmap.

#Sepsis #HAIs #MedicalDevices #Biomarkers #MarketForecasts #Healthcare #Diagnostics #mrx

[Kalorama Information @KaloramaInfo]

Want to know where #IVD is heading and how to position for 2026 and beyond? Join tomorrow’s FREE Worldwide IVD Tests #webinar covering key market drivers, growth through 2030, and competitive insights across leading global suppliers.

https://t.co/SmZLQtO5kC

#diagnostics #mrx

[Kalorama Information @KaloramaInfo]

Hear from Daniel Granderson, Editor at @KaloramaInfo, as he shares research insights on two of the industry’s hottest areas--#AtHomeTesting and #Sepsis.

https://t.co/yd0ZKnpX11

#IVD #Diagnostics #MedicalDiagnostics #InfectiousDisease #PointOfCare #POCT #DecentralizedCare #mrx

[Kalorama Information @KaloramaInfo]

Hear from Daniel Granderson, Editor at @KaloramaInfo, as he shares research insights on two of the industry’s hottest areas--#AtHomeTesting and #Sepsis.

https://t.co/yd0ZKnpX11

#IVD #Diagnostics #MedicalDiagnostics #InfectiousDisease #PointOfCare #POCT #DecentralizedCare #mrx

[Kalorama Information @KaloramaInfo]

WATCH NOW: @KaloramaInfo's webinar on "Global Trends & Growth Opportunities in the IVD Market 2025"

https://t.co/M0x5Ia8PfW

#IVD #webinar #InVitroDiagnostics #Diagnostics #Healthcare #Medical #StrategicBriefing #marketresearch #mrx

[Kalorama Information @KaloramaInfo]

The global sepsis diagnostics market is dynamic, but without reliable data on end-user spending, R&D can feel like a gamble. Kalorama's report turns uncertainty into a strategic roadmap.

#Sepsis #HAIs #MedicalDevices #Biomarkers #MarketForecasts #Healthcare #Diagnostics #mrx

[Kalorama Information @KaloramaInfo]

WATCH NOW: @KaloramaInfo's webinar on "Global Trends & Growth Opportunities in the IVD Market 2025"

https://t.co/M0x5Ia8PfW

#IVD #webinar #InVitroDiagnostics #Diagnostics #Healthcare #Medical #StrategicBriefing #marketresearch #mrx

[Kalorama Information @KaloramaInfo]

Data is only as valuable as the decisions it enables. Our report, #Biomarkers in #Diagnostics, provides the strategic intelligence you need to make confident, data-driven decisions.

https://t.co/AxmRFCb6Wq

#BiomarkerMarket #DiagnosticTrends #StrategicPlanning #Healthcare #mrx

[Kalorama Information @KaloramaInfo]

Kalorama's "#Benchmarking for 2025: Understanding the IVD User Experience" explores how #IVD vendors can enhance #CustomerExperience to strengthen relationships & drive growth.

Learn more: https://t.co/Yz1Oqa5RPC

#Diagnostics #Healthcare #MarketResearch #Invitrodiagnostics #mrx

[Kalorama Information @KaloramaInfo]

20 years strong! @KaloramaInfo continues to lead in IVD market insights.

Where is #IVD in 2025—and where is it headed by 2030? "Worldwide Market for In Vitro Diagnostic Tests, 18th Edition" has the answers.

https://t.co/Q6HIppTZEX

#Diagnostics #Healthcare #InVitroDiagnostics

[Kalorama Information @KaloramaInfo]

Companion diagnostics is on track for double-digit growth through 2029 but success requires a strategic roadmap. @KaloramaInfo is here to help

https://t.co/KLUSTfZiNo

#CompanionDiagnostics #CDx #PrecisionMedicine #NGS #MarketAnalysis #Biotech #Pharma #Healthcare #marketresearch

[Kalorama Information @KaloramaInfo]

Companion diagnostics is on track for double-digit growth through 2029 but success requires a strategic roadmap. @KaloramaInfo is here to help

https://t.co/KLUSTfZiNo

#CompanionDiagnostics #CDx #PrecisionMedicine #NGS #MarketAnalysis #Biotech #Pharma #Healthcare #marketresearch

[Science Magazine @ScienceMagazine]

New @SciSignal findings show that cells called leukocytes have a surface “coating” that can be modified during inflammatory conditions, such as #psoriasis, revealing how immune cells are recruited to sites of inflammation. https://t.co/lOzjyL46sU

[Kalorama Information @KaloramaInfo]

20 years strong! @KaloramaInfo continues to lead in IVD market insights.

Where is #IVD in 2025—and where is it headed by 2030? "Worldwide Market for In Vitro Diagnostic Tests, 18th Edition" has the answers.

https://t.co/Q6HIppTZEX

#Diagnostics #Healthcare #InVitroDiagnostics

[Kalorama Information @KaloramaInfo]

Kalorama's "#Benchmarking for 2025: Understanding the IVD User Experience" explores how #IVD vendors can enhance #CustomerExperience to strengthen relationships & drive growth.

Learn more: https://t.co/Yz1Oqa5RPC

#Diagnostics #Healthcare #MarketResearch #Invitrodiagnostics #mrx

[Kalorama Information @KaloramaInfo]

Data is only as valuable as the decisions it enables. Our report, #Biomarkers in #Diagnostics, provides the strategic intelligence you need to make confident, data-driven decisions.

https://t.co/AxmRFCb6Wq

#BiomarkerMarket #DiagnosticTrends #StrategicPlanning #Healthcare #mrx

[Kalorama Information @KaloramaInfo]

What’s trending in the #IVD biomarker industry? Watch the latest video from @KaloramaInfo for key insights, and explore our full report: "#Biomarkers in #Diagnostics: Global Strategic Insights & Forecasts"

https://t.co/HtdfaYOC4J

#invitrodiagnostics #healthcare #mrx #medical

[Kalorama Information @KaloramaInfo]

What’s trending in the #IVD biomarker industry? Watch the latest video from @KaloramaInfo for key insights, and explore our full report: "#Biomarkers in #Diagnostics: Global Strategic Insights & Forecasts"

https://t.co/HtdfaYOC4J

#invitrodiagnostics #healthcare #mrx #medical

[Diagnostics World @DXWorldNews]

What’s next for diagnostics? 🔬

Our new research highlights the biggest challenges, emerging technologies, and opportunities to improve patient outcomes over the next 5 years.

📖 Read the full study: https://t.co/LzQKwQ1oaX

#Diagnostics #HealthcareInnovation #LifeSciences #DiagnosticsWorld #Immunodiagnostics

[Global Leaders Group on AMR @GLGAMR]

Today @WHO released its latest reports on #antibacterial agents in clinical and preclinical development, and on #diagnostics that are already available or in the pipeline to detect and identify priority #bacteria listed in the WHO bacterial priority pathogens list (BPPL). https://t.co/rEB3JKL285

This is an opportunity to remind all stakeholders to work together to address the pipeline and access crisis for #antibiotics and #diagnostics https://t.co/PGkqP0ZVLd